Attachment A8 - Type 2 Provider Intro Slides

Assessing Care and Health Outcomes Among Ryan White HIV/AIDS Program (RWHAP) Clients Who Do Not Receive RWHAP-Funded Outpatient Ambulatory Health Services (OAHS)

Introductory meeting with
<Provider Name>
<Date>

Start with introductions of who is on the call starting with MPR, Mission, Amenity, and then the Type 2 provider participants.

The Ryan White HIV/AIDS Program funds services for people living with HIV in the United States. The HIV/AIDS Bureau (HAB), in the Health Resources and Services Administration (HRSA), administers the Ryan White program, and is studying the service use and outcomes of its clients who receive medical care for their HIV disease outside the Ryan White program.

Your organization was selected for our study because you provide non-OAHS services to Ryan White-eligible clients. Some of these clients receive medical care from a non-RWHAP provider and therefore, have no clinical data reported to HRSA HAB. Your site and 29 others were randomly selected from the group of providers and organizations meeting our study criteria.

HAB has hired Mathematica Policy Research, along with its partners Mission Analytics Group and Amenity Consulting, to speak with providers who provide medical care outside the Ryan White program. We ask for your support in identifying the non-Ryan White medical provider that provides medical care to some of your clients. We will contact this provider separately to assess their willingness to participate in the study.

<number>

<number>

 

Purpose of this orientation

• •Introduce new federal study conducted by HRSA 

• •Provide overview of study background and site visit goals 

• •Discuss your interest in participating in the study, including data collection activities and level of effort 

• •Review timeline for activities such as interviews and medical record abstraction 

<number>

<number>

<number>

 

Motivation for study

• •RWHAP funds a comprehensive set of medical and support services for over half a million PLWH in the United States 

• •Providers funded by RWHAP submit client-level data to the HRSA each year to monitor retention in care, initiation of ART, and viral suppression, among other outcomes 

• •There are critical gaps in HRSA HAB’s knowledge about process and clinical outcomes for clients who receive medical care from providers outside the RWHAP system 

<number>

The Ryan White HIV/AIDS Program (RWHAP) funds a comprehensive set of services for people living with HIV in the United States. Grants are administered to eligible metropolitan areas and transitional grant areas, states and territories, and community-based organizations. These grants facilitate the delivery of medical care and support services to People Living with HIV who would otherwise not have access to these services. In 2016 the RWHAP funded more than 2,000 grant recipients and subrecipients for at least one service and delivered care to more than 550,000 unique clients across the country. Nevertheless, viral load and medical service use data are unavailable for approximately 1/3 of Ryan White clients who receive medical care from a provider not funded by Ryan White for Outpatient Ambulatory Health Services.

<number>

<number>

 

Goals of study

<number>

• • 1. 1.To understand the health care service use patterns and process and clinical outcomes for RWHAP clients who do not receive HIV medical care from a RWHAP provider 

    2. 2.To identify program opportunities, if needed, to improve the coordination and delivery of medical care to PLWH who access services outside the RWHAP 

The goal of the study is to assess the health outcomes of Ryan White clients who receive medical care outside the Ryan White program. We also want to learn how to improve client experiences with getting HIV medical services and with achieving and maintaining viral suppression.

HRSA has asked us to conduct site visits with both Ryan White HIV/AIDS Program and non-Ryan White medical providers to explore the health services and outcomes of People Living with HIV. Clinical data, such as medical visits, antiretroviral therapy (ART) and viral load, are unavailable for Ryan White clients who receive their medical care from providers not funded by Ryan White for outpatient ambulatory health services (OAHS).

Do you have medical information in your case management notes?

<number>

<number>

 

Data collection goals

• •To understand health care use and health outcomes for clients not receiving HIV medical care from a RWHAP provider. 

• •To identify program improvement opportunities to better coordinate and deliver HIV medical care to PLWH who access services outside the RWHAP 

• •To conduct two primary data collection activities: 

• • –Interview clinical staff involved in providing medical care to clients 

  • –Conduct chart reviews to collect client clinical data 

<number>

<number>

<number>

 

This is NOT an evaluation of your program

The overall goal of the study is to
understand service use and health outcomes
for clients not receiving RWHAP-funded OAHS

<number>

 

Four ways you  benefit from participating

7

<number>

<number>

Boyd Gilman2018-12-17T11:48:09.102000000

this slide is identical to type 1.  Are we offering to provide the Type 2 summary data as well as Type 1?  I'm wondering if the specific benefits of participation are the same for both types of providers.

 

Overview of data collection

8

<number>

<number>

 

What we need from you

• •Contact person to assist with 

• • –Scheduling medical director and clinical staff interviews 

  • –Abstracting clinical data for up to 50 clients 

  • –Executing study contracting materials 

• •Notify your staff about the study and share with them the fact sheet that we have developed 

• •Participate in at least one additional phone call to coordinate interviews and medical record abstraction 

<number>

 

Approximate timeline of site visit activities

<number>

Activity	Week (estimates)
1.Conduct orientation call	Week 1 (August 2019)
2.Execute contract, and BAA with provider	Week 3 (August–September 2019)
3.Schedule interviews	Week 4 (August–September 2019)
4.Conduct interviews and chart abstraction (if applicable)	Week 8–10 (December 2019)
5.Submit request for honorarium	Week 11 (January 2019)
6.Provide summary of clinical data	After completing data analysis for all 30 sites (March–April 2020)

 

THANK YOU!

• •A member of our team will contact you to support your decision to participate 

• •Please contact <name of person> at <number and email> if you have additional questions after today’s call 

<number>

 

File Type	application/vnd.openxmlformats-officedocument.presentationml.presentation
File Modified	0000-00-00
File Created	0000-00-00

---

© 2024 OMB.report | Privacy Policy

---